全球生物技術香精市場

預計到 2032 年，全球生技香料市場規模將達到 23 億美元。

全球生技香精市場規模預計在2025年為14億美元，在2025年至2032年的分析期間內將以6.9%的複合年成長率成長，到2032年達到23億美元。本報告分析的細分市場之一「香草味」預計將以5.5%的複合年成長率成長，並在分析期結束時達到8.585億美元。 「水果味」細分市場預計在整個分析期內將以7.0%的複合年成長率成長。

美國市場規模估計為 4.394 億美元，而中國市場預計將以 10.6% 的複合年成長率成長。

美國生物技術香精市場預計到2025年將達到4.394億美元。作為世界第二大經濟體，中國預計在2025年至2032年的分析期間將以10.6%的複合年成長率成長，到2032年市場規模將達到5.494億美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期內將分別以3.9%和6.7%的複合年成長率成長。在歐洲，德國預計將以約4.9%的複合年成長率成長。

全球生物技術香精市場－主要市場趨勢與促進因素概述

生物技術風味正在如何改變食品和飲料產業？

生物技術香精正以其永續且創新的香精生產方式，徹底改變食品飲料產業。與源自天然或人工成分的傳統香精不同，生物技術香精是透過微生物發酵和生物轉化生產的。這包括利用基因改造生物（GMO）和酵素來複製天然成分風味的工藝。這種方法具有許多優勢，例如更高的效率、更穩定的品質以及更低的環境影響。隨著消費者對天然和永續成分的需求日益成長，生物技術香精正成為企業順應市場健康意識和環境責任趨勢的關鍵要素。

利用生物技術進行香料製造的最新技術創新有哪些？

近年來，生物技術在香精生產領域的進步正推動著該市場的顯著成長和創新。精準發酵、基因編輯和合成生物學等技術的應用，使得以往難以或成本高昂地從天然資源中提取的複雜稀有香精成為可能。例如，生技公司現在可以大規模生產香草和甜菊等稀有香精，而無需消耗天然資源。此外，代謝工程的創新提高了香精生產的效率，從而降低了時間和成本。這些技術也幫助製造商開發出符合日益成長的「潔淨標示」產品需求的香精，因為透過發酵過程獲得的生物技術衍生香精可以作為「天然」產品進行銷售。

哪些產業正在推動對生物技術香精的需求？

食品飲料產業是生物技術香精需求的主要驅動力，其應用範圍廣泛，涵蓋零食、飲料、乳製品和糖果甜點等各類產品。隨著消費者偏好轉向植物來源飲食和有機產品，生物技術香精在植物來源肉類替代品、無乳製品和有機飲料中的應用日益廣泛。機能性食品的興起，不僅提供基本營養，還帶來其他健康益處，也加速了對既能提升風味又不影響健康益處的生物技術香精的需求。此外，化妝品和個人護理行業也順應清潔美容的潮流，開始採用生物技術香精，追求天然永續的香氛。

哪些因素推動了成長？

生物技術香精市場的成長受多種因素驅動，包括消費者對天然、永續和潔淨標示產品的需求不斷成長，以及發酵和基因編輯等生物技術製程的進步。植物來源和機能性食品的日益普及也推動了對創新天然香精的需求。此外，監管機構對生物技術香精作為人工香精更安全的替代品給予支持，也促進了市場成長。香精生產商加大研發投入，以及個人化營養的日益普及，預計將在未來幾年進一步推動生技香精市場的發展。

部分：

用途（乳製品、飲料、糖果甜點、植物冰淇淋、烘焙產品、營養保健品及其他用途）、口味（香草/香草精、水果口味及其他口味）

大公司

• Bell Flavors &Fragrances, Inc.
• DSM-Firmenich SA
• Givaudan SA
• International Flavors &Fragrances, Inc.
• Kerry Group Plc
• Robertet Group
• Sensient Technologies Corporation
• Symrise AG
• T. Hasegawa Co., Ltd.
• Takasago International Corporation

目錄

第1章：調查方法

第2章執行摘要

• 市場概覽
• 大公司
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 澳洲
• 印度
• 韓國
• 亞太其他地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東國家
• 非洲

第4章 競賽

Global Biotech Flavors Market to Reach US$2.3 Billion by 2032

The global market for Biotech Flavors estimated at US$1.4 Billion in the year 2025, is expected to reach US$2.3 Billion by 2032, growing at a CAGR of 6.9% over the analysis period 2025-2032. Vanilla Type, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$858.5 Million by the end of the analysis period. Growth in the Fruity Flavor Type segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$439.4 Million While China is Forecast to Grow at 10.6% CAGR

The Biotech Flavors market in the U.S. is estimated at US$439.4 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$549.4 Million by the year 2032 trailing a CAGR of 10.6% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Biotech Flavors Market - Key Trends & Drivers Summarized

How Are Biotech Flavors Transforming the Food and Beverage Industry?

Biotech flavors are revolutionizing the food and beverage industry by providing a sustainable and innovative approach to flavor production. Unlike traditional flavors derived from natural or artificial sources, biotech flavors are produced through microbial fermentation or bioconversion, which involves using genetically modified organisms (GMOs) or enzymes to replicate the taste of natural ingredients. This method offers several advantages, including higher efficiency, consistent quality, and reduced environmental impact. As consumers increasingly demand natural and sustainable ingredients, biotech flavors are becoming a critical component for companies looking to align with health-conscious and eco-friendly trends in the market.

What Are the Latest Technological Innovations in Biotech Flavor Production?

Recent technological advancements in biotech flavor production are driving significant growth and innovation in this market. The use of precision fermentation, gene editing, and synthetic biology is enabling the creation of complex and rare flavors that are otherwise difficult or costly to extract from natural sources. For instance, biotech companies are now able to produce rare flavors like vanilla and stevia in large quantities without depleting natural resources. Additionally, innovations in metabolic engineering are improving the efficiency of flavor production, reducing both the time and costs involved. These technologies are also helping manufacturers develop flavors that meet the growing demand for clean-label products, as biotech flavors can be marketed as "natural" when derived from fermentation processes.

Which Industries Are Driving the Demand for Biotech Flavors?

The primary industries driving the demand for biotech flavors include the food and beverage sector, where they are used in everything from snacks and beverages to dairy products and confectionery. As consumer preferences shift toward plant-based diets and organic products, biotech flavors are increasingly being used in plant-based meat alternatives, dairy-free products, and organic beverages. The rise of functional foods, which offer health benefits beyond basic nutrition, has also accelerated the demand for biotech flavors that enhance taste without compromising on health claims. Moreover, the cosmetics and personal care industries are tapping into biotech flavors for natural and sustainable fragrances, aligning with the broader trend toward clean beauty.

What Factors Are Driving Growth?

The growth in the biotech flavors market is driven by several factors, including the increasing consumer demand for natural, sustainable, and clean-label products, as well as advancements in biotechnological processes such as fermentation and gene editing. The rising popularity of plant-based and functional foods is also contributing to the demand for innovative, naturally derived flavors. Furthermore, regulatory support for biotechnologically produced flavors as a safer alternative to artificial flavors is bolstering market growth. The increasing investment in research and development (R&D) by flavor companies and the growing trend toward personalized nutrition are expected to further propel the biotech flavors market in the coming years.

SCOPE OF STUDY:

The report analyzes the Biotech Flavors market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Dairy Products, Beverages, Confectionery Products, Non-Dairy Ice-Cream, Bakery Products, Nutraceuticals, Other Applications); Flavor (Vanilla & Vanillin, Fruity, Other Flavors)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Bell Flavors & Fragrances, Inc.
• DSM-Firmenich SA
• Givaudan SA
• International Flavors & Fragrances, Inc.
• Kerry Group Plc
• Robertet Group
• Sensient Technologies Corporation
• Symrise AG
• T. Hasegawa Co., Ltd.
• Takasago International Corporation

WHAT SETS THIS REPORT APART FROM OTHERS?

Validated Sources - Human-curated validation and ranking of original source content, not AI LLM-generated synthetic content which dominates the internet today and has become a quick fix for most published research reports these days. Unlike most other published sources, our customers have access to full-stack source content. Our report draws from "real intelligence" balancing the power of AI against the risks of synthetically generated content and resulting biases. Customers have access to the source feeds.

Domain Expert Insights - Domain expert insights curated from enterprise, industry, academia, and government, consolidated from multilingual multimedia formats of text, voice, and images comprise a significant resource. Customers can request access to the pool of domain experts we track for this research project. We track 21 domain experts and their insights as part of this research project. Our customers may access our online tracker.

Annual subscription - Recommended for maximum value for your research dollar. Provides one additional full update during the 12 months and access to our research portal and interactive 10-user peer-to-peer collaboration drawing from our entire stack of validated project data which is updated on a weekly basis. Platform also enables adding enterprise data or third-party licensed content to build bespoke versions. Includes competitor tracking of up to 50 companies featured in the report.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Biotechnology - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Biotechnology in Drug Development and Personalized Medicine
  • Technological Innovations in CRISPR, Gene Editing, and Synthetic Biology
  • Growing Applications of Biotechnology in Agriculture for GMO Crops and Biofertilizers
  • Advancements in Biomanufacturing Processes Driving Efficiency and Scalability
  • Expanding Role of Biotechnology in Environmental Sustainability and Biofuels
  • Increasing Investments in Healthcare and Biopharmaceutical Research & Development
  • Rising Adoption of Biotechnology in Diagnostics and Precision Medicine
  • Opportunities for Biotechnology Expansion in Emerging Markets
  • Growing Focus on Biotechnological Solutions to Address Climate Change and Global Food Security
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 2: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 3: World 13-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 4: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 5: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 6: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 7: World Biotechnology Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • TABLE 8: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 9: World Historic Review for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 10: World 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceuticals Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 12: World Historic Review for Biopharmaceuticals Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 13: World 13-Year Perspective for Biopharmaceuticals Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 14: World Recent Past, Current & Future Analysis for Bioprocess Equipment & Consumables Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 15: World Historic Review for Bioprocess Equipment & Consumables Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 16: World 13-Year Perspective for Bioprocess Equipment & Consumables Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 17: World Recent Past, Current & Future Analysis for Reagents & Kits Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 18: World Historic Review for Reagents & Kits Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 19: World 13-Year Perspective for Reagents & Kits Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 20: World Recent Past, Current & Future Analysis for Bioservices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 21: World Historic Review for Bioservices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 22: World 13-Year Perspective for Bioservices Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 23: World Recent Past, Current & Future Analysis for Bioinformatics Platforms & Software Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 24: World Historic Review for Bioinformatics Platforms & Software Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 25: World 13-Year Perspective for Bioinformatics Platforms & Software Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 27: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 28: World 13-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 29: World Recent Past, Current & Future Analysis for DNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 30: World Historic Review for DNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 31: World 13-Year Perspective for DNA Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 32: World Recent Past, Current & Future Analysis for Nanobiotechnology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 33: World Historic Review for Nanobiotechnology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 34: World 13-Year Perspective for Nanobiotechnology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 35: World Recent Past, Current & Future Analysis for Tissue Engineering & Regeneration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 36: World Historic Review for Tissue Engineering & Regeneration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 37: World 13-Year Perspective for Tissue Engineering & Regeneration Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 38: World Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 39: World Historic Review for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 40: World 13-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 41: World Recent Past, Current & Future Analysis for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 42: World Historic Review for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 43: World 13-Year Perspective for Chromatography Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 44: World Recent Past, Current & Future Analysis for Gene Amplification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 45: World Historic Review for Gene Amplification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 46: World 13-Year Perspective for Gene Amplification Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 47: World Recent Past, Current & Future Analysis for Synthetic Biology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 48: World Historic Review for Synthetic Biology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 49: World 13-Year Perspective for Synthetic Biology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 50: World Recent Past, Current & Future Analysis for CRISPR & Gene-Editing Tools Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 51: World Historic Review for CRISPR & Gene-Editing Tools Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 52: World 13-Year Perspective for CRISPR & Gene-Editing Tools Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 53: World Recent Past, Current & Future Analysis for Biochips & Microarrays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 54: World Historic Review for Biochips & Microarrays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 55: World 13-Year Perspective for Biochips & Microarrays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 56: World Recent Past, Current & Future Analysis for Health & Red Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 57: World Historic Review for Health & Red Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 58: World 13-Year Perspective for Health & Red Biotechnology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 59: World Recent Past, Current & Future Analysis for Food & Agriculture Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 60: World Historic Review for Food & Agriculture Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 61: World 13-Year Perspective for Food & Agriculture Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 62: World Recent Past, Current & Future Analysis for Industrial Processing Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 63: World Historic Review for Industrial Processing Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 64: World 13-Year Perspective for Industrial Processing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 65: World Recent Past, Current & Future Analysis for Environmental & Natural Resources Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 66: World Historic Review for Environmental & Natural Resources Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 67: World 13-Year Perspective for Environmental & Natural Resources Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 68: World Recent Past, Current & Future Analysis for Bioinformatics & Omics Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 69: World Historic Review for Bioinformatics & Omics Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 70: World 13-Year Perspective for Bioinformatics & Omics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 71: World Recent Past, Current & Future Analysis for Biopharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 72: World Historic Review for Biopharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 73: World 13-Year Perspective for Biopharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 74: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 75: World Historic Review for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 76: World 13-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 77: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 78: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 79: World 13-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 80: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 81: World Historic Review for Hospitals & Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 82: World 13-Year Perspective for Hospitals & Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 83: World Recent Past, Current & Future Analysis for Agricultural Corporations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 84: World Historic Review for Agricultural Corporations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 85: World 13-Year Perspective for Agricultural Corporations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 86: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 87: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 88: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

• UNITED STATES
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 89: USA Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 90: USA Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 91: USA 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 92: USA Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 93: USA Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 94: USA 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 95: USA Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 96: USA Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 97: USA 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 98: USA Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 99: USA Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 100: USA 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 101: Canada Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 102: Canada Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 103: Canada 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 104: Canada Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 105: Canada Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 106: Canada 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 107: Canada Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 108: Canada Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 109: Canada 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 110: Canada Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 111: Canada Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 112: Canada 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• JAPAN
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 113: Japan Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 114: Japan Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 115: Japan 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 116: Japan Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 117: Japan Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 118: Japan 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 119: Japan Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 120: Japan Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 121: Japan 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 122: Japan Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 123: Japan Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 124: Japan 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• CHINA
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 125: China Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 126: China Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 127: China 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 128: China Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 129: China Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 130: China 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 131: China Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 132: China Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 133: China 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 134: China Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 135: China Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 136: China 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• EUROPE
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 137: Europe Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 138: Europe Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 139: Europe 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 140: Europe Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 141: Europe Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 142: Europe 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 143: Europe Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 144: Europe Historic Review for Biotechnology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 145: Europe 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 146: Europe Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 147: Europe Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 148: Europe 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 149: Europe Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 150: Europe Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 151: Europe 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• FRANCE
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 152: France Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 153: France Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 154: France 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 155: France Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 156: France Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 157: France 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 158: France Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 159: France Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 160: France 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 161: France Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 162: France Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 163: France 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• GERMANY
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 165: Germany Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 166: Germany 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 167: Germany Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 168: Germany Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 169: Germany 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 170: Germany Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 171: Germany Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 172: Germany 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 173: Germany Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 174: Germany Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 175: Germany 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 176: Italy Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 177: Italy Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 178: Italy 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 180: Italy Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 181: Italy 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 182: Italy Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 183: Italy Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 184: Italy 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 185: Italy Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 186: Italy Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 187: Italy 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 188: UK Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 189: UK Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 190: UK 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 191: UK Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 192: UK Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 193: UK 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 194: UK Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 195: UK Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 196: UK 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 197: UK Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 198: UK Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 199: UK 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SPAIN
  • TABLE 200: Spain Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 201: Spain Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 202: Spain 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 203: Spain Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 204: Spain Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 205: Spain 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 206: Spain Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 207: Spain Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 208: Spain 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 210: Spain Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 211: Spain 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• RUSSIA
  • TABLE 212: Russia Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 213: Russia Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 214: Russia 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 215: Russia Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 216: Russia Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 217: Russia 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 218: Russia Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 219: Russia Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 220: Russia 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 221: Russia Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 222: Russia Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 223: Russia 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 225: Rest of Europe Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 226: Rest of Europe 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 228: Rest of Europe Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 229: Rest of Europe 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 231: Rest of Europe Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 232: Rest of Europe 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 234: Rest of Europe Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 235: Rest of Europe 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AUSTRALIA
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
• INDIA
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
• SOUTH KOREA
• REST OF ASIA-PACIFIC
• LATIN AMERICA
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • TABLE 236: Latin America Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 237: Latin America Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 238: Latin America 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 239: Latin America Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 240: Latin America Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 241: Latin America 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 242: Latin America Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 243: Latin America Historic Review for Biotechnology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 244: Latin America 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • TABLE 245: Latin America Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 246: Latin America Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 247: Latin America 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 249: Latin America Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 250: Latin America 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ARGENTINA
  • TABLE 251: Argentina Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 252: Argentina Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 253: Argentina 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 254: Argentina Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 255: Argentina Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 256: Argentina 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 257: Argentina Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 258: Argentina Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 259: Argentina 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 260: Argentina Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 261: Argentina Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 262: Argentina 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• BRAZIL
  • TABLE 263: Brazil Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 264: Brazil Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 265: Brazil 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 266: Brazil Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 267: Brazil Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 268: Brazil 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 269: Brazil Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 270: Brazil Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 271: Brazil 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 272: Brazil Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 273: Brazil Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 274: Brazil 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• MEXICO
  • TABLE 275: Mexico Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 276: Mexico Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 277: Mexico 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 278: Mexico Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 279: Mexico Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 280: Mexico 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 281: Mexico Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 282: Mexico Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 283: Mexico 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 284: Mexico Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 285: Mexico Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 286: Mexico 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF LATIN AMERICA
  • TABLE 287: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 288: Rest of Latin America Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 289: Rest of Latin America 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 290: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 291: Rest of Latin America Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 292: Rest of Latin America 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 294: Rest of Latin America Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 295: Rest of Latin America 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 297: Rest of Latin America Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 298: Rest of Latin America 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• MIDDLE EAST
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • TABLE 299: Middle East Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 300: Middle East Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 301: Middle East 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 302: Middle East Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 303: Middle East Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 304: Middle East 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 305: Middle East Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 306: Middle East Historic Review for Biotechnology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 307: Middle East 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • TABLE 308: Middle East Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 309: Middle East Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 310: Middle East 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 312: Middle East Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 313: Middle East 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• IRAN
  • TABLE 314: Iran Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 315: Iran Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 316: Iran 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 317: Iran Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 318: Iran Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 319: Iran 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 320: Iran Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 321: Iran Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 322: Iran 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 323: Iran Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 324: Iran Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 325: Iran 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ISRAEL
  • TABLE 326: Israel Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 327: Israel Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 328: Israel 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 329: Israel Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 330: Israel Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 331: Israel 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 332: Israel Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 333: Israel Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 334: Israel 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 335: Israel Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 336: Israel Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 337: Israel 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SAUDI ARABIA
  • TABLE 338: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 339: Saudi Arabia Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 340: Saudi Arabia 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 341: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 342: Saudi Arabia Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 343: Saudi Arabia 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 345: Saudi Arabia Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 346: Saudi Arabia 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 348: Saudi Arabia Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 349: Saudi Arabia 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• UNITED ARAB EMIRATES
  • TABLE 350: UAE Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 351: UAE Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 352: UAE 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 353: UAE Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 354: UAE Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 355: UAE 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 356: UAE Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 357: UAE Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 358: UAE 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 359: UAE Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 360: UAE Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 361: UAE 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF MIDDLE EAST
  • TABLE 362: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 363: Rest of Middle East Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 364: Rest of Middle East 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 365: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 366: Rest of Middle East Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 367: Rest of Middle East 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 369: Rest of Middle East Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 370: Rest of Middle East 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 372: Rest of Middle East Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 373: Rest of Middle East 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AFRICA
  • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • TABLE 374: Africa Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 375: Africa Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 376: Africa 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
  • TABLE 377: Africa Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 378: Africa Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 379: Africa 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
  • TABLE 380: Africa Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 381: Africa Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 382: Africa 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
  • TABLE 383: Africa Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 384: Africa Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 385: Africa 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION